Penumbra, Inc. (PEN)
NYSE · Common · CUSIP 70975L107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PEN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
70975L107
Market Cap
Large Cap · $1 Billion
IPO
9/17/2015 · $30.00/share
Business: Penumbra, Inc. is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra has approximately 1,000 employees and sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets.

Company Contact

CEO
Adam Elsesser
CFO
Sri Kosaraju
Headquarters
One Penumbra Place, 1351 Harbor Bay Parkway, Alameda, CA 94502
Phone
510-748-3200 · Toll-Free 888-272-4606
Investor Relations
Sara Thompson · 888-272-4606 · investors@penumbrainc.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »